Hirsch FR - Search Results

1

Mulshine JL, Smith RA, Field JK, Hirsch FR. Mulshine JL, et al. Among authors: hirsch fr. Lancet. 2002 Dec 14;360(9349):1979-80; author reply 1981. doi: 10.1016/S0140-6736(02)11880-0. Lancet. 2002. PMID: 12493299 No abstract available.

2

Lung cancer chemoprevention: moving from concept to a reality.

Mulshine JL, Hirsch FR. Mulshine JL, et al. Among authors: hirsch fr. Lung Cancer. 2003 Aug;41 Suppl 1:S163-74. doi: 10.1016/s0169-5002(03)00160-0. Lung Cancer. 2003. PMID: 12867075 Review.

3

IV international conference on prevention and early detection of lung cancer, Reykjavik, Iceland, August 9-12, 2001.

Hirsch FR, Bunn PA Jr, Dmitrovsky E, Field JK, Franklin WA, Greenberg RE, Hansen HH, Henschke CI, Rigas JR, Smith RA, Toennesen P, Mulshine JL. Hirsch FR, et al. Lung Cancer. 2002 Sep;37(3):325-44. doi: 10.1016/s0169-5002(02)00141-1. Lung Cancer. 2002. PMID: 12234703 No abstract available.

4

Lung cancer screening by spiral CT. What is the optimal target population for screening trials?

van Klaveren RJ, de Koning HJ, Mulshine J, Hirsch FR. van Klaveren RJ, et al. Among authors: hirsch fr. Lung Cancer. 2002 Dec;38(3):243-52. doi: 10.1016/s0169-5002(02)00222-2. Lung Cancer. 2002. PMID: 12445745

5

Developing CT image-processing tools to accelerate progress in lung cancer drug development.

Mulshine JL, Avila RS, Hirsch FR, Yankelevitz D. Mulshine JL, et al. Among authors: hirsch fr. Oncology (Williston Park). 2006 Nov;20(12):1606, 1608-10, 1614 passim. Oncology (Williston Park). 2006. PMID: 17153911 Free article. Review. No abstract available.

6

Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations.

Field JK, Brambilla C, Caporaso N, Flahault A, Henschke C, Herman J, Hirsch F, Lachmann P, Lam S, Maier S, Montuenga LM, Mulshine J, Murphy M, Pullen J, Spitz M, Tockman M, Tyndale R, Wistuba I, Youngson J. Field JK, et al. Int J Oncol. 2002 Aug;21(2):369-73. doi: 10.3892/ijo.21.2.369. Int J Oncol. 2002. PMID: 12118333 Review.

7

The biology of epidermal growth factor receptor in lung cancer.

Scagliotti GV, Selvaggi G, Novello S, Hirsch FR. Scagliotti GV, et al. Among authors: hirsch fr. Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4227s-4232s. doi: 10.1158/1078-0432.CCR-040007. Clin Cancer Res. 2004. PMID: 15217963 Review.

8

Epidermal growth factor receptor family in lung cancer and premalignancy.

Franklin WA, Veve R, Hirsch FR, Helfrich BA, Bunn PA Jr. Franklin WA, et al. Among authors: hirsch fr. Semin Oncol. 2002 Feb;29(1 Suppl 4):3-14. doi: 10.1053/sonc.2002.31520. Semin Oncol. 2002. PMID: 11894009 Review.

9

HER2/neu expression in malignant lung tumors.

Hirsch FR, Franklin WA, Veve R, Varella-Garcia M, Bunn PA Jr. Hirsch FR, et al. Semin Oncol. 2002 Feb;29(1 Suppl 4):51-8. doi: 10.1053/sonc.2002.31523. Semin Oncol. 2002. PMID: 11894014

10

The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis.

Bremnes RM, Veve R, Hirsch FR, Franklin WA. Bremnes RM, et al. Among authors: hirsch fr. Lung Cancer. 2002 May;36(2):115-24. doi: 10.1016/s0169-5002(01)00471-8. Lung Cancer. 2002. PMID: 11955645 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

474 results

Search Page

Filters